Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: Gastric inhibitory polypeptide receptor (GIP) Glucagon-like peptide-1 receptor (GLP-1) Glucagon receptors (GCG) This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications
GST pull-down was mixed with cell lysates from HEK293T cells, washed, and immunoblotted for NMHC-IIA and GST
+
Specifically, the study measured increases in body weight gain, longitudinal and cross-sectional bone growth, and alkaline phosphatase activity as a marker of osteoblast function
About The Author Marguerite Weston, MD, IFMCP, is a functional medicine doctor in Columbus, Ohio
A doctor may prescribe them for individuals with T2D who also have heart or kidney problems